vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and FRANKLIN ELECTRIC CO INC (FELE). Click either name above to swap in a different company.

FRANKLIN ELECTRIC CO INC is the larger business by last-quarter revenue ($500.4M vs $487.7M, roughly 1.0× CLOVER HEALTH INVESTMENTS, CORP.). FRANKLIN ELECTRIC CO INC runs the higher net margin — 6.9% vs -10.1%, a 17.0% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 9.9%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -4.0%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Franklin Electric Co., Inc. is a manufacturer and distributor of products and systems focused on the movement and management of water and energy. The company offers pumps, motors, drives, and controls for use in a variety of residential, commercial, agricultural, industrial, and municipal applications. Headquartered in Fort Wayne, Indiana, the company also operates manufacturing facilities in the United States, Germany, Czech Republic, Italy, Turkey, Mexico, Brazil, Australia, South Africa, C...

CLOV vs FELE — Head-to-Head

Bigger by revenue
FELE
FELE
1.0× larger
FELE
$500.4M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+34.8% gap
CLOV
44.7%
9.9%
FELE
Higher net margin
FELE
FELE
17.0% more per $
FELE
6.9%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-4.0%
FELE

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
FELE
FELE
Revenue
$487.7M
$500.4M
Net Profit
$-49.3M
$34.7M
Gross Margin
35.0%
Operating Margin
-10.1%
9.6%
Net Margin
-10.1%
6.9%
Revenue YoY
44.7%
9.9%
Net Profit YoY
-123.2%
10.6%
EPS (diluted)
$0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
FELE
FELE
Q1 26
$500.4M
Q4 25
$487.7M
$506.9M
Q3 25
$496.6M
$581.7M
Q2 25
$477.6M
$587.4M
Q1 25
$462.3M
$455.2M
Q4 24
$337.0M
$485.7M
Q3 24
$331.0M
$531.4M
Q2 24
$356.3M
$543.3M
Net Profit
CLOV
CLOV
FELE
FELE
Q1 26
$34.7M
Q4 25
$-49.3M
$39.3M
Q3 25
$-24.4M
$16.7M
Q2 25
$-10.6M
$60.1M
Q1 25
$-1.3M
$31.0M
Q4 24
$-22.1M
$33.7M
Q3 24
$-9.2M
$54.6M
Q2 24
$7.4M
$59.1M
Gross Margin
CLOV
CLOV
FELE
FELE
Q1 26
35.0%
Q4 25
33.8%
Q3 25
35.9%
Q2 25
36.1%
Q1 25
36.0%
Q4 24
33.8%
Q3 24
24.5%
35.7%
Q2 24
30.3%
36.8%
Operating Margin
CLOV
CLOV
FELE
FELE
Q1 26
9.6%
Q4 25
-10.1%
10.2%
Q3 25
-4.9%
14.6%
Q2 25
-2.2%
15.0%
Q1 25
-0.3%
9.7%
Q4 24
-6.4%
8.9%
Q3 24
-2.7%
13.8%
Q2 24
2.0%
14.6%
Net Margin
CLOV
CLOV
FELE
FELE
Q1 26
6.9%
Q4 25
-10.1%
7.7%
Q3 25
-4.9%
2.9%
Q2 25
-2.2%
10.2%
Q1 25
-0.3%
6.8%
Q4 24
-6.6%
6.9%
Q3 24
-2.8%
10.3%
Q2 24
2.1%
10.9%
EPS (diluted)
CLOV
CLOV
FELE
FELE
Q1 26
$0.77
Q4 25
$0.87
Q3 25
$0.37
Q2 25
$1.31
Q1 25
$0.67
Q4 24
$0.73
Q3 24
$1.17
Q2 24
$1.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
FELE
FELE
Cash + ST InvestmentsLiquidity on hand
$78.3M
$80.4M
Total DebtLower is stronger
$134.4M
Stockholders' EquityBook value
$308.7M
$1.3B
Total Assets
$541.0M
$2.0B
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
FELE
FELE
Q1 26
$80.4M
Q4 25
$78.3M
$99.7M
Q3 25
$102.9M
Q2 25
$104.6M
Q1 25
$84.0M
Q4 24
$194.5M
$220.5M
Q3 24
$288.0M
$106.3M
Q2 24
$254.8M
$58.1M
Total Debt
CLOV
CLOV
FELE
FELE
Q1 26
$134.4M
Q4 25
$135.2M
Q3 25
$135.2M
Q2 25
$14.5M
Q1 25
$14.9M
Q4 24
$11.6M
Q3 24
$11.6M
Q2 24
$87.2M
Stockholders' Equity
CLOV
CLOV
FELE
FELE
Q1 26
$1.3B
Q4 25
$308.7M
$1.3B
Q3 25
$340.9M
$1.3B
Q2 25
$344.2M
$1.3B
Q1 25
$336.1M
$1.3B
Q4 24
$341.1M
$1.3B
Q3 24
$342.2M
$1.3B
Q2 24
$324.9M
$1.2B
Total Assets
CLOV
CLOV
FELE
FELE
Q1 26
$2.0B
Q4 25
$541.0M
$1.9B
Q3 25
$559.7M
$2.0B
Q2 25
$575.0M
$2.0B
Q1 25
$583.7M
$1.9B
Q4 24
$580.7M
$1.8B
Q3 24
$653.0M
$1.8B
Q2 24
$674.2M
$1.8B
Debt / Equity
CLOV
CLOV
FELE
FELE
Q1 26
0.10×
Q4 25
0.10×
Q3 25
0.10×
Q2 25
0.01×
Q1 25
0.01×
Q4 24
0.01×
Q3 24
0.01×
Q2 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
FELE
FELE
Operating Cash FlowLast quarter
$-66.9M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
FELE
FELE
Q1 26
Q4 25
$-66.9M
$104.2M
Q3 25
$12.1M
$102.7M
Q2 25
$5.4M
$51.5M
Q1 25
$-16.3M
$-19.5M
Q4 24
$34.8M
$110.3M
Q3 24
$50.0M
$116.1M
Q2 24
$44.8M
$36.4M
Free Cash Flow
CLOV
CLOV
FELE
FELE
Q1 26
Q4 25
$-69.0M
$88.7M
Q3 25
$11.4M
$91.3M
Q2 25
$4.8M
$39.9M
Q1 25
$-16.5M
$-26.3M
Q4 24
$33.3M
$97.5M
Q3 24
$49.6M
$106.6M
Q2 24
$44.4M
$26.1M
FCF Margin
CLOV
CLOV
FELE
FELE
Q1 26
Q4 25
-14.1%
17.5%
Q3 25
2.3%
15.7%
Q2 25
1.0%
6.8%
Q1 25
-3.6%
-5.8%
Q4 24
9.9%
20.1%
Q3 24
15.0%
20.1%
Q2 24
12.5%
4.8%
Capex Intensity
CLOV
CLOV
FELE
FELE
Q1 26
Q4 25
0.4%
3.1%
Q3 25
0.1%
2.0%
Q2 25
0.1%
2.0%
Q1 25
0.0%
1.5%
Q4 24
0.5%
2.6%
Q3 24
0.1%
1.8%
Q2 24
0.1%
1.9%
Cash Conversion
CLOV
CLOV
FELE
FELE
Q1 26
Q4 25
2.65×
Q3 25
6.14×
Q2 25
0.86×
Q1 25
-0.63×
Q4 24
3.28×
Q3 24
2.13×
Q2 24
6.04×
0.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons